Isogenica
PrivateLast Round
VC Round
May 6, 2008
Company Overview
Isogenica is a biotechnology company that operates as a contract research organization specializing in the discovery and engineering of small-format VHH single-domain antibodies for therapeutic and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isogenica Comparables
Compare Isogenica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| YUMAB GmbH | 87% | |
| Crescendo Biologics Ltd. | 82% | |
| Adimab | 82% | |
Isogenica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 6, 2008 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors grew 77% MoM.
- May 2, 2025
Monthly visitors increased 32% MoM.
Isogenica Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Isogenica's valuation, stock price, and market status.